PUBLICATIONS
Moonka DK, Hyland RH, Arterburn S, Dvory-Sobol H, Brainard
DM, McHutchison JG, Terrault NA. N Engl J Med. 2016 Nov
24;375(21):2106-2108. Charlton M, O’Leary JG, Curry MP, Nader F, Henry L, Hunt S. Clin
Gastroenterol Hepatol. 2016 Nov 12. pii: S1542-3565(16)31050-3.
doi: 10.1016/j.cgh.2016.10.037.
Predicting renal recovery after liver transplant with severe
pretransplant subacute kidney injury: The impact of warm
ischemic time. Laskey HL, Schomaker N, Hung KW, Asrani SK.
Jennings L, Nydam TL, Gralla J, Wiseman A, Rosen HR, Biggins
SW. Liver Transpl. 2016 Jun 15. doi: 10.1002/lt.24488. Steroid Responsive Acute Rejection Should Not be the Endpoint
for Immunosuppressive Trials. Klintmalm GB, Vincenti F, Kirk A.
Am J Transplant. 2016 May 27. doi: 10.1111/ajt.13889.
The Influence of Immunosuppressive Agents on the Risk of De Novo
Donor-Specific HLA Antibody Production in Solid Organ Transplant
Recipients. O’Leary JG, Samaniego M, Barrio MC, Potena L, Zeevi
A, Djamali A, Cozzi E. Transplantation. 2016 Jan;100(1):39-53. doi:
10.1097/TP.0000000000000869.
Prevention and treatment of liver allograft antibody-mediated
rejection and the role of the ‘two-hit hypothesis’. Kim PT,
Demetris AJ, O’Leary JG. Curr Opin Organ Transplant.
2016 Feb 25.
Protecting the kidney in liver transplant candidates Practice-
Based Recommendations from the American Society of
Transplantation Liver and Intestine Community of Practice.
O’Leary JG, Levitsky J, Wong F, Nadim MK, Charlton M, Kim WR.
Am J Transplant. 2016 Mar 17. doi: 10.1111/ajt.13790.
Protecting the kidney in liver transplant recipients. Levitsky J,
O’Leary JG, Asrani S, Sharma P, Fung J, Wiseman A, Niemann CU.
Am J Transplant. 2016 Mar 1. doi: 10.1111/ajt.13765.
Routine Ultrasonography Surveillance of Native Kidneys for
Renal Cell Carcinoma in Kidney Transplant Candidates. Klein J,
Gonzalez SA, Fischbach BV, Yango AF, Rajagopal A, Rice KM, Saim
M, Barri YM, Melton LB, Klintmalm GB, Chandrakantan A. Clin
Transplant. 2016 May 24. doi: 10.1111/ctr.12769.
Safety and efficacy of 2-octyl-cyanoacrylate in the management of
patients with gastric and duodenal varices who are not candidates
for transjugular intrahepatic portosystemic shunts. Lizardo-
Sanchez L, Burdick J, Trotter JF. Proc (Bayl Univ Med Cent). 2016
Oct;29(4):371-373.
Safety and efficacy of simeprevir plus sofosbuvir with or without
ribavirin in patients with decompensated genotype 1 hepatitis C
cirrhosis. Modi AA, Nazario H, Trotter JF, Gautam M, Weinstein
J, Mantry P, Barnes M, Habib A, McAfee J, Teachenor O, Tujague
L, Gonzalez S. Liver Transpl. 2016 Mar;22(3):281-6. doi: 10.1002/
lt.24324.
Severe Cholestasis and Bile Acid Nephropathy From Anabolic
Steroids Successfully Treated With Plasmapheresi s. Flores A,
Nustas R, Nguyen HL, Rahimi RS. ACG Case Rep J. 2016 Jan
20;3(2):133-5. doi: 10.14309/crj.2016.24.
Sofosbuvir and simeprevir in hepatitis C genotype 1-patients with
end-stage renal disease on haemodialysis or GFR <30 ml/min.
Nazario HE, Ndungu M, Modi AA. Liver Int. 2016 Jun;36(6):798-
801. doi: 10.1111/liv.13025.
Sofosbuvir and Velpatasvir Combination Improves Outcomes
Reported by Patients With HCV Infection, Without or with
Compensated or Decompensated Cirrhosis. Younossi ZM,
Stepanova M, Feld J, Zeuzem S, Sulkowski M, Foster GR, Mangia A,
The INR is only one side of the coagulation cascade: time to
watch the clot. Ramsay MA, Trotter JF. Anaesthesia. 2016 Mar 31.
doi: 10.1111/anae.13480.
Terlipressin plus albumin is more effective than albumin alone
in improving renal function in patients with cirrhosis and
hepatorenal syndrome type 1. Boyer TD, Sanyal AJ, Wong F,
Frederick RT, Lake JR, O’Leary JG, Ganger D, Jamil K, Pappas SC;
REVERSE Study Investigators. Gastroenterology. 2016 Feb 16. pii:
S0016-5085(16)00217-1. doi: 10.1053/j.gastro.2016.02.026.
Transfusing common sense instead of blood products into
coagulation testing in patients with cirrhosis: Overtreatment ≠
safety. Rahimi RS, O’leary JG. Hepatology. 2016 Feb;63(2):368-70.
doi: 10.1002/hep.28291.
Unresectable Hepatocellular Carcinoma Due to Portal Venous
Thrombosis: Focal Stereotactic Body Radiation Therapy Can
Promote Resectability. Lee AY, Wu T, Vannier MW, Testa G, Liauw
SL. J Gastrointest Cancer. 2012 Sep;43 Suppl 1:S202-7. doi: 10.1007/
s12029-012-9387-0.
Use of a Pressure Wire to Evaluate Right Heart Pressures in a pre-
Liver Transplant Recipient Through a Peripheral IV. Schussler JM,
Asrani SK, Ramsay MA, Trotter JF. Liver Transpl. 2016 Mar 8. doi:
10.1002/lt.24432.
HEART AND LUNG TRANSPLANTATION
Atrophy of the Heart After Insertion of a Left Ventricular Assist
Device and Closure of the Aortic Valve. Roberts WC, Hall SA, Ko
JM, McCullough PA, Lima B. The American Journal of Cardiology.
2016;117(5):878-9.
Comparison of Characteristics of Patients Undergoing Heart
Transplantation at the Same Hospital in Two Different Time
Periods (1997-2012 and 2013-2015). Roberts WC, Won VS,
Vasudevan A, Kapoor P, Ko JM, Meyer DM, Hall SA, Gonzalez-
Stawinski GV. Am J Cardiol. 2016 Jul 15;118(2):288-91. doi:
10.1016/j.amjcard.2016.04.031.
Comparison of Outcomes of Operative Therapy for Acute Type
A Aortic Dissections Provided at High-Volume Versus Low-
Volume Medical Centers in North Texas. Arsalan M, Squiers JJ,
47